Clinical Trial

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

Name: Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial — clinical trial record (NCT03322995)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PANC

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, phase II study in patients with resectable and borderline resectable pancreas cancer.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2017-10-24; most recent amendment 2026-01-06.

Status change: Not Yet Recruiting → Recruiting 2018-07-06

Trial Details

NCT Number	NCT03322995
Lead Sponsor	Medical College of Wisconsin
Conditions	Pancreatic Cancer
Enrollment	125 participants
Start Date	2018-06-21
Primary Completion	2027-06-01 (estimated)
Study Completion	2032-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-08